Financial Ratios

SHASUN PHARMACEUTICALS LTD.- (AMALGAMATION)

NSE : NABSE : 524552ISIN CODE : INE317A01028Industry : Pharmaceuticals & DrugsHouse : Private
BSE428.850 (0 %)
PREV CLOSE ( ) 428.85
OPEN PRICE ( ) 410.00
BID PRICE (QTY) 428.85 (3881)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 79828
TODAY'S LOW / HIGH ( )407.80 432.05
52 WK LOW / HIGH ( ) 407.8432.05
NSE
This Company is not listed in NSE
Select year
ParticularsMar2015Mar2014Mar2013Mar2012Mar2011
Operational & Financial Ratios
   Earnings Per Share (Rs)6.886.224.649.631.00
   CEPS(Rs)13.0112.9610.2314.115.99
   DPS(Rs)0.001.001.502.400.30
   Book NAV/Share(Rs)65.2955.4050.1746.8335.25
   Tax Rate(%)9.77-26.03-11.19-42.3541.66
Margin Ratios
   Core EBITDA Margin(%)10.879.878.446.826.70
   EBIT Margin(%)8.957.206.218.975.28
   Pre Tax Margin(%)4.122.892.934.931.44
   PAT Margin (%)3.713.653.267.020.84
   Cash Profit Margin (%)7.027.607.1810.305.01
Performance Ratios
   ROA(%)3.363.433.238.310.85
   ROE(%)11.7111.799.6924.722.57
   ROCE(%)10.799.068.4515.257.55
   Asset Turnover(x)0.910.940.991.181.01
   Sales/Fixed Asset(x)1.641.711.641.781.52
   Working Capital/Sales(x)-34.71-15.05-13.03-56.13-24.87
Efficiency Ratios
   Fixed Capital/Sales(x)0.610.580.610.560.66
   Receivable days95.3195.5794.4480.93102.16
   Inventory Days64.8062.2057.8852.0850.09
   Payable days139.67137.61124.68106.26115.09
Valuation Parameters
   PER(x)53.9611.3714.428.6851.71
   PCE(x)28.535.466.545.928.67
   Price/Book(x)5.681.281.331.781.47
   Yield(%)0.001.412.242.870.58
   EV/Net Sales(x)2.610.990.990.940.81
   EV/Core EBITDA(x)20.858.589.517.488.39
   EV/EBIT(x)28.2613.2915.5210.2015.00
   EV/CE(x)2.130.810.850.970.82
   M Cap / Sales2.070.430.480.630.44
Growth Ratio
   Net Sales Growth(%)15.3719.416.3729.766.89
   Core EBITDA Growth(%)25.4231.62-11.5768.43-17.52
   EBIT Growth(%)43.3338.65-26.03120.74-24.32
   PAT Growth(%)17.3834.05-50.47987.92-77.90
   EPS Growth(%)10.5534.05-51.79858.10-78.00
Financial Stability Ratios
   Total Debt/Equity(x)1.491.701.420.921.28
   Current Ratio(x)0.960.900.880.970.93
   Quick Ratio(x)0.670.610.610.690.61
   Interest Cover(x)1.851.671.892.221.37
   Total Debt/Mcap(x)0.261.331.060.520.87

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.